Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フ

Japan's day, wrapped and delivered by morning.

Article Archive

All Tokyo Brief articles

1085 articles · newest first

  1. Aug 3, 2026 · 2 min read

    Eisai's Alzheimer's Drug Leqembi Grows 27% as Quarterly Profit Jumps 26%

    Lenvima, Leqembi and Dayvigo again did the heavy lifting for Eisai's first quarter, with Leqembi's Americas sales up 71% masking a China pullback tied to last year's distributor stocking, while the drugmaker left its full-year targets exactly where it set them in May.

  2. Aug 3, 2026 · 2 min read

    Shionogi Books 90% of Its First-Half Profit Target in One Quarter

    A string of drugmaker acquisitions, not stronger underlying sales, pushed Shionogi's quarterly net profit up 148% to ¥97.7bn, covering most of its own first-half profit guidance within three months while cutting its cash pile by more than half.

  3. Aug 3, 2026 · 2 min read

    Seven & i's ¥400bn Buyback Comes With a Price Tag Set Later

    Seven & i Holdings landed ¥100,300 short of its ¥400bn share-buyback ceiling in a single Tokyo Stock Exchange trade on August 3, and nearly ¥367bn of that deal carries a placeholder price that SMBC Nikko Securities will true up later against the stock's future trading average.